Literature DB >> 2475964

Determination of homovanillic acid, 5-hydroxyindoleacetic acid and pressure in the cerebrospinal fluid of collie dogs following administration of ivermectin.

D M Vaughn1, S T Simpson, B L Blagburn, W L Whitmer, R Heddens-Mysinger, C M Hendrix.   

Abstract

Twelve adult Collie dogs were studied to determine the effects of ivermectin on neurotransmitter metabolites released from the brain into the cerebrospinal fluid (CSF) and on CSF pressure. Ten of the 12 Collies were given ivermectin orally at a concentration of 200 micrograms/kg body weight. Three of these 10 Collies showed clinical signs of ivermectin-induced toxicosis which progressed into a state of unresponsive recumbency in 2 dogs. Cerebrospinal fluid pressures and neurotransmitter metabolite concentrations in cisterna magna CSF were analysed 49 to 50 hours after administration of ivermectin in 6 of the 10 treated dogs, and in the 2 untreated control Collies. Cerebrospinal fluid pressures were within normal limits in all dogs. However, compared to the CSF concentrations in the 2 untreated and 3 non-reactive Collies, the 2 ivermectin-reactive Collies still in recumbency had elevated CSF concentrations of homovanillic acid (HVA), a metabolite of dopamine, and 5-hydroxyindoleacetic acid (5-HIAA), a metabolite of serotonin. These findings suggest an association between altered neurotransmission and severe ivermectin-induced neurological abnormalities. No evidence of elevated intracranial pressure was found.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475964     DOI: 10.1007/bf00366852

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  15 in total

1.  Pharmacological properties of the postsynaptic inhibition by Purkinje cell axons and the action of gamma-aminobutyric acid on deiters NEURONES.

Authors:  K Obata; M Ito; R Ochi; N Sato
Journal:  Exp Brain Res       Date:  1967       Impact factor: 1.972

2.  GABA receptor pharmacology. Functional considerations.

Authors:  S J Enna
Journal:  Biochem Pharmacol       Date:  1981-05-01       Impact factor: 5.858

3.  Rapid, concurrent analysis of dopamine, 5-hydroxytryptamine, their precursors and metabolites utilizing high performance liquid chromatography with electrochemical detection: analysis of brain tissue and cerebrospinal fluid.

Authors:  J A Nielsen; C A Johnston
Journal:  Life Sci       Date:  1982-12-20       Impact factor: 5.037

4.  The dopamine-gamma aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments.

Authors:  M Herrera-Marschitz; U Ungerstedt
Journal:  Acta Physiol Scand       Date:  1987-03

5.  Clinical observations in collies given ivermectin orally.

Authors:  A J Paul; W J Tranquilli; R L Seward; K S Todd; J A DiPietro
Journal:  Am J Vet Res       Date:  1987-04       Impact factor: 1.156

6.  Value of monoamine metabolite determinations in CSF as an index of their concentrations in rat brain following various pharmacological manipulations.

Authors:  M G Palfreyman; S Huot; J Wagner
Journal:  J Pharmacol Methods       Date:  1982-11

7.  Neurotransmitter modifications in human cerebrospinal fluid and serum during hepatic encephalopathy.

Authors:  J Borg; J M Warter; J L Schlienger; M Imler; C Marescaux; G Mack
Journal:  J Neurol Sci       Date:  1982-12       Impact factor: 3.181

8.  GABA and dopamine interaction in the basal ganglia: dopaminergic supersensitivity following chronic elevation of brain gamma-aminobutyric acid levels.

Authors:  S P Sivam; P M Hudson; H A Tilson; J S Hong
Journal:  Brain Res       Date:  1987-05-26       Impact factor: 3.252

9.  Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.

Authors:  D M Vaughn; E Coleman; S T Simpson; C Satjawatcharaphong
Journal:  Am J Vet Res       Date:  1988-08       Impact factor: 1.156

10.  Ivermectin: a potent new antiparasitic agent.

Authors:  W C Campbell; M H Fisher; E O Stapley; G Albers-Schönberg; T A Jacob
Journal:  Science       Date:  1983-08-26       Impact factor: 47.728

View more
  3 in total

1.  Ivermectin excretion by isolated functionally intact brain endothelial capillaries.

Authors:  S Nobmann; B Bauer; G Fricker
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

2.  Diagnostic ophthalmology.

Authors:  J Wolfer; B Grahn; S Lane
Journal:  Can Vet J       Date:  1997-11       Impact factor: 1.008

Review 3.  Treatment of MDR1 mutant dogs with macrocyclic lactones.

Authors:  Joachim Geyer; Christina Janko
Journal:  Curr Pharm Biotechnol       Date:  2012-05       Impact factor: 2.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.